We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+1.29%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$5.23B
AUM Growth
-$356M
Cap. Flow
-$292M
Cap. Flow %
-5.58%
Top 10 Hldgs %
6.49%
Holding
1,401
New
76
Increased
301
Reduced
335
Closed
120

Top Buys

Rank Stock Value
1
WAT icon
Waters Corp
WAT
+$37.7M
2
STLD icon
Steel Dynamics
STLD
+$16.9M
3
OKE icon
Oneok
OKE
+$15M
4
SCHW
Charles Schwab
SCHW
+$14.3M
5
PNR icon
Pentair
PNR
+$13.7M

Sector Composition

Rank Sector Weight
1 Financials 26.04%
2 Consumer Discretionary 12.02%
3 Industrials 11.98%
4 Technology 10.21%
5 Healthcare 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARAV
1151
DELISTED
Aravive, Inc. Common Stock
ARAV
$307K 0.01%
82,625
+50,000
+153% +$213K
IRBT
1152
DELISTED
iRobot
IRBT
$306K 0.01%
3,900
GPUS
1153
Hyperscale Data Inc
GPUS
$55.4M
$306K 0.01%
1
SMIT
1154
DELISTED
Schmitt Industries Inc
SMIT
$304K 0.01%
70,802
BFI
1155
DELISTED
BurgerFi International, Inc. Common Stock
BFI
$303K 0.01%
35,000
TAIT
1156
DELISTED
Taitron Components
TAIT
$302K 0.01%
78,500
DBD
1157
DELISTED
Diebold Nixdorf Incorporated
DBD
$302K 0.01%
29,900
SIF icon
1158
SIFCO Industries
SIF
$176M
$301K 0.01%
35,024
CALC icon
1159
CalciMedica
CALC
$10.9M
$299K 0.01%
+6,429
New +$361K
ADMA icon
1160
ADMA Biologics
ADMA
$2.22B
$297K 0.01%
263,100
-100,000
-28% -$140K
SCPS
1161
DELISTED
Scopus BioPharma Inc. Common Stock
SCPS
$294K 0.01%
70,866
+23,857
+51% +$123K
PNBK icon
1162
Patriot National Bancorp
PNBK
$136M
$288K 0.01%
27,500
-10,000
-27% -$93.1K
PYPL icon
1163
PayPal
PYPL
$50.5B
$286K 0.01%
1,100
MACK
1164
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$286K 0.01%
59,200
NATH icon
1165
Nathan's Famous
NATH
$402M
$281K 0.01%
4,600
GSIT icon
1166
GSI Technology
GSIT
$258M
$279K 0.01%
52,917
PSTL
1167
Postal Realty Trust
PSTL
$699M
$278K 0.01%
14,900
SGRP
1168
DELISTED
SPAR Group
SGRP
$271K 0.01%
194,637
+169,637
+679% +$275K
ICAD
1169
DELISTED
iCAD Inc
ICAD
$270K 0.01%
25,100
-900
-3% -$11.7K
CTEK
1170
DELISTED
CynergisTek, Inc.
CTEK
$270K 0.01%
150,000
CVR icon
1171
Chicago Rivet & Machine Co
CVR
$10.3M
$269K 0.01%
10,000
OPNT
1172
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$268K 0.01%
10,400
WVFC
1173
DELISTED
WVS Financial Corp
WVFC
$268K 0.01%
+16,800
New +$269K
CDTX
1174
DELISTED
Cidara Therapeutics
CDTX
$266K 0.01%
5,944
TRT
1175
Trio-Tech International
TRT
$113M
$260K 0.01%
123,200

Similar funds

Bridgeway Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Bridgeway Capital Management held 1,401 positions worth $5.23B, down 6.4% from $5.59B the previous quarter. Its ten largest holdings account for 6.5% of the portfolio.

Bridgeway Capital Management withdrew a net $292M in Q3 2021, closing 120 positions and reducing 335 holdings. Its most notable exit was Expeditors International, an estimated $24.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Bridgeway Capital Management opened a new position in Waters Corp worth $34.4M.

  • Bridgeway Capital Management's largest Q3 2021 buy was Waters Corp: 96,160 shares worth $34.4M.
  • Bridgeway Capital Management added most to Target in Q3 2021, an estimated $8.25M increase.
  • Bridgeway Capital Management's biggest Q3 2021 reduction was United Parcel Service, cutting an estimated $20M.
  • Bridgeway Capital Management fully exited Expeditors International in Q3 2021, selling an estimated $24.9M.
  • Bridgeway Capital Management's ten largest holdings make up 6.5% of its $5.23B portfolio in Q3 2021.
  • Bridgeway Capital Management opened 76 new positions and closed 120 in Q3 2021.
  • Bridgeway Capital Management's portfolio value fell 6.4% quarter-over-quarter to $5.23B.

Based on Bridgeway Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.